Diabetes in Children and Adolescents

  • América Liliana Miranda Lora
  • Martha Beauregard Paz
  • Miguel Klünder Klünder


Diabetes mellitus is one of the most common chronic diseases in pediatric patients. Although type 1 diabetes is the most common in children and adolescents, and type 2 diabetes has increased in these age groups, there are other types of diabetes with lower frequency that affect this population, such as monogenic diabetes, drug- or chemical-induced diabetes, and cystic fibrosis-related diabetes, among others. The diagnostic criteria for diabetes mellitus and increased risk of diabetes (prediabetes) are essentially the same as in adults; however, there are unique aspects of the care and management of children and adolescents with diabetes, such as changes in insulin sensitivity due to growth and development, dependence on care, and neurological susceptibility to changes in glucose. Additionally, treatment should be adapted to age-related physiological changes, which must be handled and guided by a multidisciplinary team of specialists in pediatric diabetes. It is important to provide family and individual management education to achieve a balance between adult supervision and independent self-care so that the transition from pediatric to adult health care is smooth and successful.


Diabetes mellitus Children Adolescents 


  1. 1.
    Menke A, Casagrande S, Cowie CC. Prevalence of diabetes in adolescents aged 12 to 19 years in the United States, 2005-2014. JAMA. 2016;316(3):344–5.PubMedCrossRefGoogle Scholar
  2. 2.
    American Diabetes Association. 11. Children and Adolescents. Diabetes Care. 2016;39(Suppl 1):S86–93.Google Scholar
  3. 3.
    Springer SC, Silverstein J, Copeland K, Moore KR, Prazar GE, Raymer T, et al. Management of type 2 diabetes mellitus in children and adolescents. Pediatrics. 2013;131(2):e648–64.PubMedCrossRefGoogle Scholar
  4. 4.
    American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care. 2016;39(Suppl 1):S13–S22Google Scholar
  5. 5.
    Nowicka P, Santoro N, Liu H, Lartaud D, Shaw MM, Goldberg R, et al. Utility of hemoglobin A(1c) for diagnosing prediabetes and diabetes in obese children and adolescents. Diabetes Care. 2011;34(6):1306–11.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Buse JB, Kaufman FR, Linder B, Hirst K, El Ghormli L, Willi S. Diabetes screening with hemoglobin A(1c) versus fasting plasma glucose in a multiethnic middle-school cohort. Diabetes Care. 2013;36(2):429–35.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Rubio-Cabezas O, Hattersley AT, Njolstad PR, Mlynarski W, Ellard S, White N, et al. ISPAD Clinical Practice Consensus Guidelines 2014. The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2014;15(Suppl 20):47–64.PubMedCrossRefGoogle Scholar
  8. 8.
    Polak M, Cave H. Neonatal diabetes mellitus: a disease linked to multiple mechanisms. Orphanet J Rare Dis. 2007;2:12.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Ashcroft FM, Puljung MC, Vedovato N. Neonatal diabetes and the KATP channel: from mutation to therapy. Trends Endocrinol Metab. 2017;28:377. Scholar
  10. 10.
    Greeley SA, Naylor RN, Philipson LH, Bell GI. Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment. Curr Diab Rep. 2011;11(6):519–32.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Maassen JA, T Hart LM, Van Essen E, Heine RJ, Nijpels G, Jahangir Tafrechi RS, et al. Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes. 2004;53(1):S103–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S. Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia. 2010;53(12):2504–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Ergun-Longmire B, Maclaren NK. De Groot LJ, Chrousos G, Dungan K, et al., editors. Management of type-1 and type-2 diabetes mellitus in children. South Dartmouth: MDTextcom, Inc; 2000- Last Update: December 9, 2013.Google Scholar
  14. 14.
    Nijim Y, Awni Y, Adawi A, Bowirrat A. Classic case report of Donohue Syndrome (Leprechaunism; OMIM *246200): the impact of consanguineous mating. Medicine (Baltimore). 2016;95(6):e710.CrossRefGoogle Scholar
  15. 15.
    Resmini E, Minuto F, Colao A, Ferone D. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities. Acta Diabetol. 2009;46(2):85–95.PubMedCrossRefGoogle Scholar
  16. 16.
    Fathallah N, Slim R, Larif S, Hmouda H, Ben Salem C. Drug-induced hyperglycaemia and diabetes. Drug Saf. 2015;38(12):1153–68.PubMedCrossRefGoogle Scholar
  17. 17.
    Dabelea D, Mayer-Davis EJ, Saydah S, Imperatore G, Linder B, Divers J, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014;311(17):1778–86.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Roche EF, McKenna AM, Ryder KJ, Brennan AA, O’Regan M, Hoey HM. Is the incidence of type 1 diabetes in children and adolescents stabilising? The first 6 years of a National Register. Eur J Pediatr. 2016;175(12):1913–9.PubMedCrossRefGoogle Scholar
  19. 19.
    DIAMOND Project Group. Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med. 2006;23(8):857–66.CrossRefGoogle Scholar
  20. 20.
    Butalia S, Kaplan GG, Khokhar B, Rabi DM. Environmental risk factors and type 1 diabetes: past, present, and future. Can J Diabetes. 2016;40i(6):586–93.CrossRefGoogle Scholar
  21. 21.
    Pociot F, Lernmark A. Genetic risk factors for type 1 diabetes. Lancet. 2016;387(10035):2331–9.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Giannopoulou EZ, Winkler C, Chmiel R, Matzke C, Scholz M, Beyerlein A, et al. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes. Diabetologia. 2015;58(10):2317–23.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Ziegler AG, Rewers M, Simell O, Simell T, Lempainen J, Steck A, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA. 2013;309(23):2473–9.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Rewers M, Ludvigsson J. Environmental risk factors for type 1 diabetes. Lancet. 2016;387(10035):2340–8.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Dabelea D, Rewers A, Stafford JM, Standiford DA, Lawrence JM, Saydah S, et al. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study. Pediatrics. 2014;133(4):e938–45.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Usher-Smith JA, Thompson M, Ercole A, Walter FM. Variation between countries in the frequency of diabetic ketoacidosis at first presentation of type 1 diabetes in children: a systematic review. Diabetologia. 2012;55(11):2878–94.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Dashti AS, Alaei MR, Musavi Z, Faramarzi R, Mansouri F, Nasimfar A. Serological response to vaccines in children with diabetes. Roum Arch Microbiol Immunol. 2015;74(3–4):112–7.PubMedGoogle Scholar
  28. 28.
    American Diabetes Association. 5. Glycemic Targets. Diabetes Care. 2016;39(Suppl 1):S39–46.Google Scholar
  29. 29.
    Ly TT, Maahs DM, Rewers A, Dunger D, Oduwole A, Jones TW. ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2014;15(Suppl 20):180–92.PubMedCrossRefGoogle Scholar
  30. 30.
    Beck JK, Cogen FR. Outpatient management of pediatric type 1 diabetes. J Pediatr Pharmacol Ther. 2015;20(5):344–57.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Phillips A. Advances in infusion sets and insulin pumps in diabetes care. Br J Community Nurs. 2016;21(3):124–7.PubMedCrossRefGoogle Scholar
  32. 32.
    Haviland N, Walsh J, Roberts R, Bailey TS. Update on clinical utility of continuous glucose monitoring in type 1 diabetes. Curr Diab Rep. 2016;16(11):115.PubMedCrossRefGoogle Scholar
  33. 33.
    Downie E, Craig ME, Hing S, Cusumano J, Chan AK, Donaghue KC. Continued reduction in the prevalence of retinopathy in adolescents with type 1 diabetes: role of insulin therapy and glycemic control. Diabetes Care. 2011;34(11):2368–73.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Zabeen B, Craig ME, Virk SA, Pryke A, Chan AK, Cho YH, et al. Insulin pump therapy is associated with lower rates of retinopathy and peripheral nerve abnormality. PLoS One. 2016;11(4):e0153033.PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Smart C. Nutritional management of diabetes in childhood. In: Koletzko B, Bhatia J, Bhutta ZA, Cooper P, Makrides M, Uauy R, et al., editors. Pediatric nutrition in practice. 2nd ed: Switzerland: Karger; 2015.Google Scholar
  36. 36.
    Smart CE, Annan F, Bruno LPC, Higgins LA, Acerini CL. ISPAD Clinical Practice Consensus Guidelines 2014 Compendium. Nutritional management in children and adolescents with diabetes. Pediatr Diabetes. 2014;15(S20):135–53.PubMedCrossRefGoogle Scholar
  37. 37.
    Nations FaAOotU, Organization WH, University UN. Energy and protein requirements. Estimates of energy and protein requirements of adults and children. Geneva: World Health Organization; 1985.Google Scholar
  38. 38.
    Organization WH, Nations FaAOotU. Vitamin and mineral requirements in human nutrition. 2nd ed. Hong Kong: World Health Organization; 2004.Google Scholar
  39. 39.
    Riddell MC, Gallen IW, Smart CE, Taplin CE, Adolfsson P, Lumb AN, et al. Exercise management in type 1 diabetes: a consensus statement. Lancet Diabetes Endocrinol. 2017;
  40. 40.
    Pivovarov JA, Taplin CE, Riddell MC. Current perspectives on physical activity and exercise for youth with diabetes. Pediatr Diabetes. 2015;16(4):242–55. Scholar
  41. 41.
    Tremblay MS, Warburton DE, Janssen I, Paterson DH, Latimer AE, Rhodes RE, et al. New Canadian physical activity guidelines. Appl Physiol Nutr Metab. 2011;36(1):36–46; 7-58.PubMedCrossRefGoogle Scholar
  42. 42.
    Tremblay MS, Leblanc AG, Carson V, Choquette L, Connor Gorber S, Dillman C, et al. Canadian physical activity guidelines for the early years (aged 0-4 years). Appl Physiol Nutr Metab. 2012;37(2):345–69.PubMedCrossRefGoogle Scholar
  43. 43.
    Tremblay MS, Carson V, Chaput JP, Connor Gorber S, Dinh T, Duggan M, et al. Canadian 24-hour movement guidelines for children and youth: an integration of physical activity, sedentary behaviour, and sleep. Appl Physiol Nutr Metab. 2016;41(6 Suppl 3):S311–27.PubMedCrossRefGoogle Scholar
  44. 44.
    Brown RJ, Rother KI. Effects of beta-cell rest on beta-cell function: a review of clinical and preclinical data. Pediatric Diabetes. 2008;9(3pt2):14–22.PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Herold KC, Gitelman SE, Masharani U, Hagopian W, Bisikirska B, Donaldson D, et al. A Single Course of Anti-CD3 Monoclonal Antibody hOKT3Î31(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes. Diabetes. 2005;54(6):1763–9.PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Raz I, Elias D, Avron A, Tamir M, Metzger M, Cohen IR. β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. The Lancet. 2001;358(9295):1749–53.
  47. 47.
    Ryan EA, Imes S, Wallace C. Short-term intensive insulin therapy in newly diagnosed type 2 diabetes. Diabetes Care. 2004;27(5):1028–32.PubMedCrossRefGoogle Scholar
  48. 48.
    Agardh C-D, Cilio CM, Lethagen ÁL, Lynch K, Leslie RDG, Palmér M, et al. Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes. J Diabetes Complications. 2005;19(4):238–46.
  49. 49.
    Alleva DG, Gaur A, Jin L, Wegmann D, Gottlieb PA, Pahuja A, et al. Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-Chain (9–23) peptide. Diabetes. 2002;51(7):2126–34.PubMedCrossRefGoogle Scholar
  50. 50.
    Reiband HK, Schmidt S, Ranjan A, Holst JJ, Madsbad S, Norgaard K. Dual-hormone treatment with insulin and glucagon in patients with type 1 diabetes. Diabetes Metab Res Rev. 2015;31(7):672–9.PubMedCrossRefGoogle Scholar
  51. 51.
    Davidson JA, Holland WL, Roth MG, Wang MY, Lee Y, Yu X, et al. Glucagon therapeutics: dawn of a new era for diabetes care. Diabetes Metab Res Rev. 2016;32(7):660–5.PubMedCrossRefGoogle Scholar
  52. 52.
    Xiang H, Yang C, Xiang T, Wang Z, Ge X, Li F, et al. Residual beta-cell function predicts clinical response after autologous hematopoietic stem cell transplantation. Stem Cells Transl Med. 2016;5(5):651–7.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Pellegrini S, Cantarelli E, Sordi V, Nano R, Piemonti L. The state of the art of islet transplantation and cell therapy in type 1 diabetes. Acta Diabetol. 2016;53(5):683–91.PubMedCrossRefGoogle Scholar
  54. 54.
    Al Khalifah RA, Alnhdi A, Alghar H, Alanazi M, Florez ID. The effect of adding metformin to insulin therapy for type 1 diabetes mellitus children: A systematic review and meta-analysis. Pediatr Diabetes. 2017;10
  55. 55.
    Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes. Diabetes Care. 2010;33(5):1004–8.PubMedCentralCrossRefPubMedGoogle Scholar
  56. 56.
    Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36(5):1384–95.PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    International Diabetes Federation, International Society for Pediatric and Adolescent Diabetes. Global IDF/ISPAD guideline for diabetes in childhood and adolescence. Brussels: International Diabetes Federation; 2011. Available from: Scholar
  58. 58.
    Brink S, Joel D, Laffel L, Lee WWR, Olsen B, Phelan H, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Sick day management in children and adolescents with diabetes. Pediatr Diabetes. 2014;15(S20):193–202.PubMedCrossRefGoogle Scholar
  59. 59.
    Rhodes ET, Gong C, Edge JA, Wolfsdorf JI, Hanas R. ISPAD Clinical Practice Consensus Guidelines 2014. Management of children and adolescents with diabetes requiring surgery. Pediatr Diabetes. 2014;15(S20):224–31.PubMedCrossRefGoogle Scholar
  60. 60.
    Wolfsdorf JI, Allgrove J, Craig M, Edge JA, Glaser N, Jain V, et al. ISPAD Clinical Practice Consensus Guidelines 2014 Compendium. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2014;15(Suppl. 20):154–79.PubMedCrossRefPubMedCentralGoogle Scholar
  61. 61.
    Hagger V, Trawley S, Hendrieckx C, Browne JL, Cameron F, Pouwer F, et al. Diabetes MILES Youth-Australia: methods and sample characteristics of a national survey of the psychological aspects of living with type 1 diabetes in Australian youth and their parents. BMC Psychol. 2016;4(1):42.PubMedPubMedCentralCrossRefGoogle Scholar
  62. 62.
    Sztein DM, Lane WG. Examination of the comorbidity of mental illness and somatic conditions in hospitalized children in the United States using the kids’ inpatient database, 2009. Hosp Pediatr. 2016;6(3):126–34.PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    American Diabetes Association. 3. Foundations of care and comprehensive medical evaluation. Diabetes Care. 2016;39(Suppl1):S23–35.Google Scholar
  64. 64.
    Hillard PJ. Prevention and management of pregnancy in adolescents with endocrine disorders. Adolesc Med State Art Rev. 2015;26(2):382–92.PubMedPubMedCentralGoogle Scholar
  65. 65.
    Bradley TJ, Slorach C, Mahmud FH, Dunger DB, Deanfield J, Deda L, et al. Early changes in cardiovascular structure and function in adolescents with type 1 diabetes. Cardiovasc Diabetol. 2016;15(10):31.PubMedPubMedCentralCrossRefGoogle Scholar
  66. 66.
    Szalai E, Deak E, Modis L Jr, Nemeth G, Berta A, Nagy A, et al. Early corneal cellular and nerve fiber pathology in young patients with type 1 diabetes mellitus identified using corneal confocal microscopy. Invest Ophthalmol Vis Sci. 2016;57(3):853–8.PubMedCrossRefPubMedCentralGoogle Scholar
  67. 67.
    Mills SA, Hofman PL, Jiang Y, Anderson YC. Health-related quality of life of Taranaki children with Type 1 Diabetes. N Z Med J. 2015;128(1427):25–32.PubMedPubMedCentralGoogle Scholar
  68. 68.
    Caferoglu Z, Inanc N, Hatipoglu N, Kurtoglu S. Health-related quality of life and metabolic control in children and adolescents with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol. 2016;8(1):67–73.PubMedPubMedCentralCrossRefGoogle Scholar
  69. 69.
    Nielsen HB, Ovesen LL, Mortensen LH, Lau CJ, Joensen LE. Type 1 diabetes, quality of life, occupational status and education level - A comparative population-based study. Diabetes Res Clin Pract. 2016;121:62–8.PubMedCrossRefGoogle Scholar
  70. 70.
    Yi-Frazier JP, Hilliard ME, Fino NF, Naughton MJ, Liese AD, Hockett CW, et al. Whose quality of life is it anyway? Discrepancies between youth and parent health-related quality of life ratings in type 1 and type 2 diabetes. Qual Life Res. 2016;25(5):1113–21.PubMedCrossRefGoogle Scholar
  71. 71.
    Pinhas-Hamiel O, Zeitler P. Clinical presentation and treatment of type 2 diabetes in children. Pediatr Diabetes. 2007;8(Suppl 9):16–27.PubMedCrossRefGoogle Scholar
  72. 72.
    Druet C, Tubiana-Rufi N, Chevenne D, Rigal O, Polak M, Levy-Marchal C. Characterization of insulin secretion and resistance in type 2 diabetes of adolescents. J Clin Endocrinol Metab. 2006;91(2):401–4.PubMedCrossRefGoogle Scholar
  73. 73.
    Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br Med Bull. 2001;60:5–20.PubMedPubMedCentralCrossRefGoogle Scholar
  74. 74.
    Sellers EA, Dean HJ, Shafer LA, Martens PJ, Phillips-Beck W, Heaman M, et al. Exposure to Gestational Diabetes Mellitus: Impact on the Development of Early-Onset Type 2 Diabetes in Canadian First Nation and Non-First Nation Offspring. Diabetes Care. 2016;39:2240–6.Google Scholar
  75. 75.
    Rosenbaum M, Fennoy I, Accacha S, Altshuler L, Carey DE, Holleran S, et al. Racial/ethnic differences in clinical and biochemical type 2 diabetes mellitus risk factors in children. Obesity (Silver Spring). 2013;21(10):2081–90.CrossRefGoogle Scholar
  76. 76.
    American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care. 2000;23(3):381–9.CrossRefGoogle Scholar
  77. 77.
    Valdez R, Greenlund KJ, Khoury MJ, Yoon PW. Is family history a useful tool for detecting children at risk for diabetes and cardiovascular diseases? A public health perspective. Pediatrics. 2007;120(2):S78–86.PubMedCrossRefGoogle Scholar
  78. 78.
    Miranda-Lora AL, Vilchis-Gil J, Molina-Díaz M, Flores-Huerta S, Klünder-Klünder M. Heritability, parental transmission and environment correlation of pediatric-onset type 2 diabetes mellitus and metabolic syndrome-related traits. Diabetes Res Clin Pract. 2017;126(4):151–9.PubMedCrossRefGoogle Scholar
  79. 79.
    Peng S, Zhu Y, Lü B, Xu F, Li X, Lai M. TCF7L2 gene polymorphisms and type 2 diabetes risk: a comprehensive and updated meta-analysis involving 121 174 subjects. Mutagenesis. 2013;28(1):25–37.PubMedCrossRefGoogle Scholar
  80. 80.
    Dabelea D, Dolan LM, D’Agostino R Jr, Hernandez AM, McAteer JB, Hamman RF, et al. Association testing of TCF7L2 polymorphisms with type 2 diabetes in multi-ethnic youth. Diabetologia. 2011;54(3):535–9.PubMedCrossRefGoogle Scholar
  81. 81.
    Miranda-Lora AL, Cruz M, Aguirre-Hernández J, Molina-Díaz M, Gutiérrez J, Flores-Huerta S, et al. Exploring single nucleotide polymorphisms previously related to obesity and metabolic traits in pediatric-onset type 2 diabetes. Acta Diabetol. 2017;54(7):653–62.Google Scholar
  82. 82.
    Zeitler P, Fu J, Tandon N, Nadeau K, Urakami T, Bartlett T, et al. ISPAD Clinical Practice Consensus Guidelines 2014 Compendium. Type 2 diabetes in the child and adolescent. Pediatr Diabetes. 2014;15(Suppl. 20):26–46.PubMedCrossRefGoogle Scholar
  83. 83.
    Barlow SE. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007;120(Supplement 4):S164–S92.PubMedCrossRefGoogle Scholar
  84. 84.
    Fitch C, Keim KS. Position of the academy of nutrition and dietetics: use of nutritive and nonnutritive sweeteners. J Acad Nutr Diet. 2012;112(5):739–58.PubMedCrossRefGoogle Scholar
  85. 85.
    Mays D, Streisand R, Walker LR, Prokhorov AV, Tercyak KP. Cigarette smoking among adolescents with type 1 diabetes: strategies for behavioral prevention and intervention. J Diabetes Complications. 2012;26(2):148–53.PubMedCrossRefGoogle Scholar
  86. 86.
    Kelsey MM, Geffner ME, Guandalini C, Pyle L, Tamborlane WV, Zeitler PS, et al. Presentation and effectiveness of early treatment of type 2 diabetes in youth: lessons from the TODAY study. Pediatr Diabetes. 2016;17(3):212–21.PubMedCrossRefGoogle Scholar
  87. 87.
    Brandt ML, Harmon CM, Helmrath MA, Inge TH, McKay SV, Michalsky MP. Morbid obesity in pediatric diabetes mellitus: surgical options and outcomes. Nat Rev Endocrinol. 2010;6(11):637–45.PubMedCrossRefGoogle Scholar
  88. 88.
    Kelly AS, Barlow SE, Rao G, Inge TH, Hayman LL, Steinberger J, et al. Severe Obesity in Children and Adolescents: Identification, Associated Health Risks, and Treatment Approaches. A Scientific Statement From the American Heart Association. Circulation. 2013;128(15):1689–712.PubMedCrossRefGoogle Scholar
  89. 89.
    Inge TH, Zeller M, García VF, Daniels SR. Surgical approach to adolescent obesity. Adolesc Med Clin. 2004;15:429–53.PubMedCrossRefGoogle Scholar
  90. 90.
    Bondada S, Jen HC, DeUgarte DA. Outcomes of bariatric surgery in adolescents. Curr Opin Pediatr. 2011;23(5):552–6.PubMedCrossRefPubMedCentralGoogle Scholar
  91. 91.
    Michalsky MP, Inge TH, Teich S, Eneli I, Miller R, Brandt ML, et al. Adolescent bariatric surgery program characteristics: The Teen Longitudinal Assessment of Bariatric Surgery (Teen-LABS) study experience. Semin Pediatr Surg. 2014;23(1):5–10.PubMedCrossRefGoogle Scholar
  92. 92.
    Williams CL, Hayman LL, Daniels SR, Robinson TN, Steinberger J, Paridon S, et al. Cardiovascular health in childhood. A statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2002;106(1):143–60.PubMedCrossRefPubMedCentralGoogle Scholar
  93. 93.
    Copeland KC, Zeitler P, Geffner M, Guandalini C, Higgins J, Hirst K, et al. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metabol. 2011;96(1):159–67.CrossRefGoogle Scholar
  94. 94.
    Eppens MC, Craig ME, Cusumano J, Hing S, Chan AKF, Howard NJ, et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care. 2006;29(6):1300–6.PubMedCrossRefPubMedCentralGoogle Scholar
  95. 95.
    Batisky DL. What is the optimal first-line agent in children requiring antihypertensive medication? Curr Hypertens Rep. 2012;14(6):603–7.PubMedPubMedCentralCrossRefGoogle Scholar
  96. 96.
    Bjornstad P, Cherney DZ, Maahs DM, Nadeau KJ. Diabetic kidney disease in adolescents with type 2 diabetes: new insights and potential therapies. Curr Diab Rep. 2016;16(2):11.PubMedPubMedCentralCrossRefGoogle Scholar
  97. 97.
    Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007;370(9588):685–97.PubMedCrossRefPubMedCentralGoogle Scholar
  98. 98.
    Amini M, Horri N, Farmani M, Haghighi S, Sattari G, Pornaghshband Z, et al. Prevalence of polycystic ovary syndrome in reproductive-aged women with type 2 diabetes. Gynecol Endocrinol. 2008;24(8):423–7.PubMedCrossRefGoogle Scholar
  99. 99.
    Nadeau KJ, Zeitler PS, Bauer TA, Brown MS, Dorosz JL, Draznin B, et al. Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity. J Clin Endocrinol Metabol. 2009;94(10):3687–95.CrossRefGoogle Scholar
  100. 100.
    Rice TB, Foster GD, Sanders MH, Unruh M, Reboussin D, Kuna ST, et al. The relationship between obstructive sleep apnea and self-reported stroke or coronary heart disease in overweight and obese adults with type 2 diabetes mellitus. Sleep. 2012;35(9):1293–8.PubMedPubMedCentralCrossRefGoogle Scholar
  101. 101.
    Foster GD, Sanders MH, Millman R, Zammit G, Borradaile KE, Newman AB, et al. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care. 2009;32(6):1017–9.PubMedPubMedCentralCrossRefGoogle Scholar
  102. 102.
    Walders-Abramson N. Depression and quality of life in youth-onset type 2 diabetes mellitus. Curr Diab Rep. 2014;14(1):449.PubMedCrossRefPubMedCentralGoogle Scholar
  103. 103.
    American Diabetes Association. 8. Pharmacologic approaches to glycemic treatment. Diabetes Care. 2017;40(Suppl 1):S64–74.CrossRefGoogle Scholar
  104. 104.
    Onda Y, Nishimura R, Morimoto A, Sano H, Utsunomiya K, Tajima N. Age at transition from pediatric to adult care has no relationship with mortality for childhood-onset type 1 diabetes in Japan: Diabetes Epidemiology Research International (DERI) Mortality Study. PLoS One. 2016;11i(3):e0150720.CrossRefGoogle Scholar

Suggested Reading

  1. American Diabetes Association. 12. Children and Adolescents. Diabetes Care. 40(Supplement 1):S105–13. In this document, the American Diabetes Association provides the components of diabetes care for children and adolescents as well as a system to grade the quality of scientific evidence supporting recommendations for health care in pediatric patients.Google Scholar
  2. ISPAD Clinical Practice Consensus Guidelines 2014. This compendium of consensus guidelines contains updates about significant advances in scientific knowledge and clinical care for pediatric and adolescent patients with diabetes mellitus.

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • América Liliana Miranda Lora
    • 1
  • Martha Beauregard Paz
    • 1
  • Miguel Klünder Klünder
    • 2
  1. 1.Research Unit of Evidence-Based Medicine, Mexico Children’s Hospital Federico GómezMexico CityMexico
  2. 2.Mexico Children’s Hospital Federico GómezMexico CityMexico

Personalised recommendations